TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis

References

• Isakoff MS, Bielack SS, Meltzer P, et al. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029–3035.
   PubMed Web of Science ®Google Scholar
• Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23(13):1494–1504.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Orfanelli U, Jachetti E, Chiacchiera F, et al. Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. Oncogene. 2015;34(16):2094–2102.
   PubMed Web of Science ®Google Scholar
• Sun T, Song Y, Yu H, et al. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis’s proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis. Cancer Biol Ther. 2019;20(6):760–773.
   PubMed Web of Science ®Google Scholar
• Xiao J, Lin L, Luo D, et al. Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance. Oncogenesis. 2020;9(3):29.
   PubMed Web of Science ®Google Scholar
• Sun G, Yan S, Shi L, et al. Decreased expression of miR-15b in human gliomas is associated with poor prognosis. Cancer Biother Radiopharm. 2015;30(4):169–173.
   PubMed Web of Science ®Google Scholar
• Sun L, Yao Y, Liu B, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene. 2012;31(4):432–445.
   PubMed Web of Science ®Google Scholar
• MacLean JA 2nd, King ML, Okuda H, et al. WNT7A regulation by miR-15b in ovarian cancer. PLoS One. 2016;11(5):e0156109.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhang N, Zhao S, et al. miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer. Oncol Lett. 2019;18(6):6491–6500.
   PubMed Web of Science ®Google Scholar
• Arakawa F, Kimura Y, Yoshida N, et al. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma. Int J Oncol. 2016;48(2):485–492.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li Y, Chen G, et al. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3. Oncol Rep. 2017;38(1):352–358.
   PubMed Web of Science ®Google Scholar
• Lambros MB, Natrajan R, Geyer FC, et al. PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Mod Pathol. 2010;23(10):1334–1345.
   PubMed Web of Science ®Google Scholar
• Li K, Liu Y, Xu S, et al. PPM1D functions as oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma. Pathol Oncol Res. 2020;26(1):387–395.
   PubMed Web of Science ®Google Scholar
• Yang S, Dong S, Qu X, et al. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC. Mol Med Rep. 2017;15(2):719–723.
   PubMed Web of Science ®Google Scholar
• Bulavin DV, Demidov ON, Saito S, et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 2002;31(2):210–215.
   PubMed Web of Science ®Google Scholar
• Long X, Lin XJ. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1. J Cell Biochem. 2019;120(4):5652–5665.
   PubMed Web of Science ®Google Scholar
• Huang B, Chang C, Wang BL, et al. ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis. J Cell Biochem. 2019;120(10):16921–16933.
   PubMed Web of Science ®Google Scholar
• Huang C, Qin Y, Liu H, et al. Downregulation of a novel long noncoding RNA TRPM2-AS promotes apoptosis in non-small cell lung cancer. Tumour Biol. 2017;39(2):1010428317691191.
   Google Scholar
• Weng Y, Shen Y, He Y, et al. The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect. Biochem Biophys Res Commun. 2018;503(4):2749–2757.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen Y, Wang M, et al. PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells. World J Surg Oncol. 2014;12(1):258.
   PubMedGoogle Scholar
• Wu B, Guo BM, Kang J, et al. PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms. Apoptosis. 2016;21(3):365–378.
   PubMed Web of Science ®Google Scholar
• Peng TS, He YH, Nie T, et al. PPM1D is a prognostic marker and therapeutic target in colorectal cancer. Exp Ther Med. 2014;8(2):430–434.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang L, Su P, et al. MicroRNA-499a-5p inhibits osteosarcoma cell proliferation and differentiation by targeting protein phosphatase 1D through protein kinase B/glycogen synthase kinase 3beta signaling. Oncol Lett. 2018;15(4):4113–4120.
   PubMed Web of Science ®Google Scholar
• Lavorgna G, Chiacchiera F, Briganti A, et al. Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell. Genom Data. 2015;3:4–5.
   PubMedGoogle Scholar
• Beermann J, Piccoli MT, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–1325.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Jiang C, Fang J. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/beta-catenin pathway. Biochem Biophys Res Commun. 2018;495(1):238–245.
   PubMed Web of Science ®Google Scholar
• Duan G, Zhang C, Xu C, et al. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR34a/cyclin D1 axis. Int J Oncol. 2019;54(1):17–28.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang L, Pan X. Long non-coding RNA TRPM2-AS promotes cell migration and invasion by serving as a ceRNA of miR-138 and inducing SOX4-mediated EMT in laryngeal squamous cell carcinoma. Cancer Manag Res. 2020;12:7805–7812.
   PubMed Web of Science ®Google Scholar
• Pan L, Li Y, Jin L, et al. TRPM2-AS promotes cancer cell proliferation through control of TAF15. Int J Biochem Cell Biol. 2020;120:105683.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang Z, Wang L, et al. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomed Pharmacother. 2019;109:991–999.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu Y, Guo J, et al. miR-148a-3p suppresses the proliferation and invasion of esophageal cancer by targeting DNMT1. Genet Test Mol Biomarkers. 2019;23(2):98–104.
   PubMed Web of Science ®Google Scholar
• Salem M, O’Brien JA, Bernaudo S, et al. miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-versican pathway. Cancer Res. 2018;78(15):4175–4190.
   PubMed Web of Science ®Google Scholar
• Rohini M, Gokulnath M, Miranda PJ, et al. miR-590-3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells. Biochimie. 2018;154:10–18.
   PubMed Web of Science ®Google Scholar
• Wu B, Liu G, Jin Y, et al. miR-15b-5p promotes growth and metastasis in breast cancer by targeting HPSE2. Front Oncol. 2020;10:108.
   PubMed Web of Science ®Google Scholar
• Sun LN, Zhi Z, Chen LY, et al. SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p. Cancer Lett. 2017;409:104–115.
   PubMed Web of Science ®Google Scholar
• Zou J, Qian J, Fu H, et al. MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: a novel insight into the pathogenesis of thyroid carcinoma. Mol Med Rep. 2020;22(4):2723–2732.
   PubMed Web of Science ®Google Scholar
• Fons NR, Sundaram RK, Breuer GA, et al. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nat Commun. 2019;10(1):3790.
   PubMedGoogle Scholar
• Tedaldi G, Tebaldi M, Zampiga V, et al. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Oncotarget. 2017;8(29):47064–47075.
   PubMedGoogle Scholar